PT1516054E - Construções de fusão contendo secções activas de ligandos tnf - Google Patents

Construções de fusão contendo secções activas de ligandos tnf Download PDF

Info

Publication number
PT1516054E
PT1516054E PT02806793T PT02806793T PT1516054E PT 1516054 E PT1516054 E PT 1516054E PT 02806793 T PT02806793 T PT 02806793T PT 02806793 T PT02806793 T PT 02806793T PT 1516054 E PT1516054 E PT 1516054E
Authority
PT
Portugal
Prior art keywords
fusion protein
sequence
recombinant fusion
component
fasl
Prior art date
Application number
PT02806793T
Other languages
English (en)
Portuguese (pt)
Inventor
Juerg Tschopp
Pascal Schneider
Oliver Gaide
Original Assignee
Topotarget Switzerland Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Topotarget Switzerland Sa filed Critical Topotarget Switzerland Sa
Publication of PT1516054E publication Critical patent/PT1516054E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT02806793T 2002-02-10 2002-08-21 Construções de fusão contendo secções activas de ligandos tnf PT1516054E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10205368 2002-02-10
DE10205583A DE10205583A1 (de) 2002-02-10 2002-02-11 Fusionskonstrukte, enthaltend aktive Abschnitte von TNF-Liganden

Publications (1)

Publication Number Publication Date
PT1516054E true PT1516054E (pt) 2010-02-17

Family

ID=27618488

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02806793T PT1516054E (pt) 2002-02-10 2002-08-21 Construções de fusão contendo secções activas de ligandos tnf

Country Status (5)

Country Link
AT (1) ATE450614T1 (da)
DE (2) DE10205583A1 (da)
DK (1) DK1516054T3 (da)
ES (1) ES2337455T3 (da)
PT (1) PT1516054E (da)

Also Published As

Publication number Publication date
DE50214059D1 (de) 2010-01-14
DE10205583A1 (de) 2003-08-21
ES2337455T3 (es) 2010-04-26
DK1516054T3 (da) 2010-04-06
ATE450614T1 (de) 2009-12-15

Similar Documents

Publication Publication Date Title
US8895003B2 (en) Pharmaceutical composition comprising EDA-1 Fusion Protein
JP6491621B2 (ja) 組織保護ペプチド及びその使用
ES2234015T3 (es) Gen relacionado con el aguti.
ES2289778T3 (es) Proteinas de fusion de la region constante de la inmunoglobulina/receptor tgf-beta tipo ii.
ES2539778T3 (es) Proteínas de fusión humanas recombinantes de EPO-Fc con vida media prolongada y actividad eritropoyética in vivo mejorada
JP6018648B2 (ja) キメラのコイルドコイル（二重コイル）分子を使用する方法
ES2281529T3 (es) Peptidos eficaces en el tratamiento de tumores y otras afecciones que requieren la eliminacion o destruccion de celulas.
JP6585720B2 (ja) 眼疾患治療のペプチド及びこれを含む眼疾患治療用組成物
WO2018032787A1 (zh) 高糖基化人生长激素融合蛋白及其制备方法与用途
JP2012520661A (ja) 抗血管新生融合タンパク質
ES2611151T3 (es) Dímero de G-CSF humano recombinante y uso del mismo para el tratamiento de enfermedades neurológicas
PT2825208T (pt) Proteína de ligação de neurotrofinas p75ntr para utilização terapêutica
KR20150111347A (ko) 듀켄씨 근이영양증의 치료에서의 폴리스타틴
KR20210041137A (ko) 노화와 연관된 질환을 치료하기 위한 방법 및 조성물
CN107530400A (zh) 使用来源于神经丝蛋白的肽治疗需要破坏或移除细胞的病症的方法
ES2300114T3 (es) Polipeptidos de fusion que comprenden un dominio de enlazamiento de ige y un componente de hsa, y sus usos diagnosticos y terapeuticos.
EA006423B1 (ru) Олигопептид, обладающий биологической активностью модулятора рецептора тромбопоэтина, и способы его применения
HU227311B1 (en) Single-chain forms of the glycoprotein hormone quartet
JP2003534363A (ja) トランスジェニック非ヒト動物由来ヒト血清アルブミン含有化粧組成物
US20150299280A1 (en) Medical treatment use of cell-membrane-permeable fibroblast growth factor
AU2003288434B2 (en) Peptides, antibodies thereto, and their use in the treatment of central nervous system damage
PT1516054E (pt) Construções de fusão contendo secções activas de ligandos tnf
EP0511816A2 (en) Neurotrophic peptide derivative
CN115073607A (zh) Tnfr2与baff受体的融合蛋白
CN115724942A (zh) TGFβRII活性改造突变体及其应用